Robert L. Page

8.2k citations

147 papers · 4.9k indexed · 4 hit papers · h-index 36

Impact in

Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
Family Practice top 0.5%
- Medication Adherence and Compliance

Papers in

Geriatrics and Gerontology 25
- Pharmaceutical Practices and Patient Outcomes 23
Transplantation 17
- Renal Transplantation Outcomes and Treatments 17

Co-authors: J. Mark Ruscin JoAnn Lindenfeld Geraldine G. Miller Barbara S. Wiggins Brian D. Lowes Ronald Zolty Eugene E. Wolfel Simon F. Shakar
Journals: Circulation (19 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (15 papers)Journal of Cardiac Failure (9 papers)Journal of the American College of Cardiology (8 papers)Annals of Pharmacotherapy (7 papers)
Partner nations: United States United Kingdom Armenia

In The Last Decade

Robert L. Page

141 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association 2022 · 145 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Circulation
2019 Arteriosclerosis Thrombosis and Vascular Biology
2016 Circulation
2016 Circulation

Peers

Countries citing papers authored by Robert L. Page

Since Specialization

Citations

This map shows the geographic impact of Robert L. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Page more than expected).

Fields of papers citing papers by Robert L. Page

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Page. The network helps show where Robert L. Page may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert L. Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Page Line = papers co-authored together Robert L. Page links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant American Journal of Transplantation ·Kyle Concannon, Robert L. Page, William Cage, Amrut V. Ambardekar, Y. А. Ginkota, Carmen González-González	2025	0
2	10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway Journal of the American College of Cardiology ·Patrick T. O’Gara, JoAnn Lindenfeld, Rebecca T Hahn, Andrés Alas Pumariño, Omar Khalique, Prateeti Khazanie, Dharam J. Kumbhani, Robert L. Page, Kristen K. Patton, Vinod H. Thourani	2025	1
3	Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical Trial Journal of Addiction Medicine ·Leone Older, SangGwan Lee, Nazila Jamshidi, 莞明田, Dina Aribah, 光二安道, Robert L. Page, О. С. Заблоцкая, Nicholas A. Buckley, C. Giocoli, Nicholas Lintzeris, Paul Haber	2024	0
4	2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update Journal of the American College of Cardiology ·Steven M. Hollenberg, Lynne W. Stevenson, Tariq Ahmad, Biykem Bozkurt, Javed Butler, Leslie L. Davis, Mark H. Drazner, James N. Kirkpatrick, Alanna A. Morris, Robert L. Page, Hasan K. Siddiqi, Alan B. Storrow, John R. Teerlink	2024	16
5	Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists Clinical Transplantation ·Nkumbe HE, Robert L. Page, Sheryl L. Chow, Tamás Alexy, Mozhgan Ghaedi	2024	2
6	Homebrew: An economical and sensitive glassmilk-based nucleic-acid extraction method for SARS-CoV-2 diagnostics Cell Reports Methods ·Robert L. Page, M. Cleveland, Mattia Ficarelli, 李丹钢, K. Ansai, Thomas J. A. Maguire, Clément R. Bouton, María José Lista, Stuart J. D. Neil, Michael H. Malim, Mark Zuckerman, Hannah E. Mischo, Rocío T. Martínez-Núñez	2022	7
7	Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices Circulation Heart Failure ·R Krolikowski, Gloria Nolen, Elvira Rosa, H. Koerber, Matthew C. Babcock, Christine M. Swanson, Ãngel LicÃ n-Trillo, Ivona Vidić Štrac, De Lawter, 蘇孟鴻, Ahmet Erulgen, Robert L. Page, Amrut V. Ambardekar, Jay D. Pal, Wendy M. Kohrt, Eugene E. Wolfel, Justin S. Lawley, Takashi Tarumi, William K. Cornwell	2021	13
8	A Randomized Controlled Trial of Heart Failure Disease Management in Skilled Nursing Facilities Journal of the American Medical Directors Association ·Rebecca S. Boxer, Mary A. Dolansky, Depita Fitriyanti, Karin Hjertaker, Abdul Faruk, Robert L. Page, Diane L. Fairclough, Stefan Gravenstein	2021	8
9	Select Drug-Drug Interactions With Direct Oral Anticoagulants Journal of the American College of Cardiology ·Barbara S. Wiggins, Dave L. Dixon, Ron Neyens, Robert L. Page, Ty J. Gluckman	2020	94
10	Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Circulation ·Robert L. Page, Larry A. Allen, Robert A. Kloner, Ratna Sari, Catherine de Martel, Alanna A. Morris, Mariann R. Piano, Jamal S. Rana, Jorge F. Saucedo	2020	138
11	Stakeholder Perspectives of the Clinical Utility of Pharmacogenomic Testing in Solid Organ Transplantation Pharmacogenomics ·A. Ryszewski, V. Beck, Shirley M. Tsunoda, Bristi Dutta, Yee Ming Lee, Heather Anderson, Robert L. Page, Jan D. Hirsch, Christina L. Aquilante	2019	12
12	Hidden Costs Associated With Venous Thromboembolism Journal of Occupational and Environmental Medicine ·Robert L. Page, Vahram Ghushchyan, Brian Gifford, Arghavan Badri Kouhi, Monika Raut, Brahim Bookhart, Ahmad Naim, C.V. Damaraju, Kavita Nair	2014	13
13	Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability Drug metabolism and drug interactions ·Larry K. Golightly, Gerard R. Barber, Michelle A. Barron, Robert L. Page	2013	17
14	Abstract 14767: Integrated Telehealth and Care Management Program Reduces All Cause Mortality in Medicare Beneficiaries with Heart Failure Circulation ·Robert L. Page, David Kao, Dendy Macaulay, Howard G. Birnbaum, Catharine Christie Dann Roeber, Urvi Desai, JoAnn Lindenfeld	2012	1
15	Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study Drug Healthcare and Patient Safety ·Robert L. Page, Marina Ponestke Seara, YASITHA KAKARLAPUDI, Aruzhan Smagulova	2011	52
16	Seizures associated with regadenoson: A case series Journal of Nuclear Cardiology ·Robert L. Page, Daniil Matveev, Jacquelyn Bainbridge, GUO Yi-Hang, Robert A. Quaife	2011	18
17	ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution Circulation ·David R. Holmes, Jeffrey Becker, Christopher B. Granger, Marian C. Limacher, Robert L. Page, Cathy Sila	2011	18
18	STATIN THERAPY IS COST-EFFECTIVE FOR VASCULAR EVENT PREVENTION IN ADULTS WITH ELEVATED C-REACTIVE PROTEIN: IMPLICATIONS OF JUPITER Journal of the American College of Cardiology ·Julia F. Slejko, Robert L. Page, Patrick W. Sullivan	2010	2
19	The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use The American journal of geriatric pharmacotherapy ·Robert L. Page, J. Mark Ruscin	2006	133
20	A Baseline Study of Medication Error Rates at Baylor University Medical Center in Preparation for Implementation of a Computerized Physician Order Entry System Baylor University Medical Center Proceedings ·Ramzi Mohammad, David Nicewander, Robert L. Page, Faria Jahan	2004	13

About Robert L. Page

Robert L. Page is a scholar working on Geriatrics and Gerontology, Transplantation, Family Practice, Toxicology and Cardiology and Cardiovascular Medicine, having authored 147 papers that have together received 4.9k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (24 papers), Pharmaceutical Practices and Patient Outcomes (23 papers), Renal Transplantation Outcomes and Treatments (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Transplantation: Methods and Outcomes (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Medication Adherence and Compliance (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). The work is most often cited by research in Geriatrics and Gerontology (828 citations), Family Practice (322 citations), Transplantation (294 citations), Cardiology and Cardiovascular Medicine (1.8k citations) and Toxicology (153 citations). Robert L. Page has collaborated with scholars based in United States, United Kingdom and Armenia. Frequent co-authors include J. Mark Ruscin, JoAnn Lindenfeld, Geraldine G. Miller, Barbara S. Wiggins, Brian D. Lowes, JoAnn Lindenfeld, Ronald Zolty, Eugene E. Wolfel, Simon F. Shakar and Joseph J. Saseen. Their work appears in journals such as Circulation, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Cardiac Failure, Journal of the American College of Cardiology and Annals of Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact